Document Detail

Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in colorectal cancer patients.
MedLine Citation:
PMID:  23319326     Owner:  NLM     Status:  Publisher    
Mortalin/GRP75 is a ubiquitous mitochondrial chaperone related to the cytosolic heat shock protein 70 (HSP70). It protects cells from senescence and apoptosis and is overexpressed in cancer cells. Cell resistance to complement-dependent cytotoxicity depends on mortalin and during complement attack mortalin is released from cells. Our goal was to determine if cancer patients have circulating mortalin in blood. The significance of mortalin in blood to survival prospects of colorectal cancer patients was evaluated. Occurrence of extracellular soluble HSP70 (sHSP70) is documented. We developed a sensitive ELISA for mortalin. The association between mortalin level and survival was subjected to the Cox Proportional hazards analysis (univariate and multivariate analyses). Mortalin concentration in serum of colorectal cancer patients was 10-214 ng/ml. Survival data of the patients was known from an earlier study of sHSP70 in these samples. Cox regression analysis indicated that high mortalin (>60ng/ml) is a risk factor for shorter survival. Serum levels of sHSP70 and mortalin in patients were independent variables. Concurrence of high sHSP70 and mortalin was associated with rapid disease progression (HR=4, 2.04-8.45, P<0.001). Addition of high sHSP70 and mortalin to a baseline model of age, sex and TNM stage, significantly (P<0.001) enhanced the risk score to 8 (3.26-20.46). This is the first demonstration of circulating mortalin in cancer patients. Analysis of mortalin in blood, and even more so of mortalin and sHSP70, adds a high prognostic value to the TNM stage and will identify colorectal cancer patients at high risk of poor survival. © 2013 Wiley Periodicals, Inc.
Perri Rozenberg; Judit Kocsis; Moran Saar; Zoltán Prohászka; George Füst; Zvi Fishelson
Related Documents :
20013316 - Trail and triptolide: an effective combination that induces apoptosis in pancreatic can...
21167526 - Tumor grade improves the prognostic ability of american joint committee on cancer stage...
24473396 - Clinical value of circulating endothelial cells and of soluble cd146 levels in patients...
19802016 - Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-indu...
21198276 - Fever/clinical signs and association with neutropenia in solid cancer patients - bacter...
19949676 - Clinical characteristics of radiation oncology in korea during past 10 years.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-15
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  -     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 UICC.
Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy.
Next Document:  Shotgun proteomics study of early biofilm formation process of Acidithiobacillus ferrooxidans ATCC 2...